Insulet launches Omnipod 5, Omnipod Discover in the Middle East
February 5, 2026
Insulet (Nasdaq:PODD) announced today that it launched its Omnipod 5 and Omnipod Discover offerings in the Middle East.
Insulet (Nasdaq:PODD) announced today that it launched its Omnipod 5 and Omnipod Discover offerings in the Middle East.
Based on a virus-like particle built with a DNA scaffold, the approach could generate broadly neutralizing antibody responses against HIV or influenza.
With this FDA approval, Hologic now offers three guideline-recommended methods: Pap testing, HPV primary testing, and co-testing.
The implantable blood pressure sensor will now be available to patients with chronic heart failure through the NHS.
Zimmer Biomet (NYSE: ZBH)+
announced today that it received FDA 510(k) clearance for its G7 acetabular system for hip replacement surgeries.
Next-generation vascular stents can make cardiovascular therapies minimally invasive and vascular treatments safe and less burdensome.
A new type of brain implant may have implications for both brain research and future treatments of neurological diseases such as epilepsy.
A study led by Dartmouth Engineering professors demonstrates a possible new technique for connecting electronic implants with the surface of the brain, as well as a new method for ensuring safe, long-term medical access to the brain.
An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as “bad” cholesterol, by up to 60%, according to a new phase three clinical trial published in the New England Journal of Medicine.
Researchers have developed a nasal spray for flu prevention that has shown promising results in preliminary human trials.